Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.20M | 7.92M | 4.80M | 4.71M | -2.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.20M | 7.92M | 4.80M | 4.71M | -2.85M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 11.20M | 7.92M | 4.80M | 4.71M | -2.85M |
| SG&A Expenses | 5.00M | 5.26M | 5.26M | 5.19M | 4.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.35M | 13.22M | 14.51M | 15.08M | 15.08M |
| Operating Income | -1.16M | -5.29M | -9.71M | -10.37M | -17.93M |
| Income Before Tax | 9.00K | -4.05M | -8.49M | -8.97M | -16.35M |
| Income Tax Expenses | 700.00 | 1.30K | 1.30K | 800.00 | 800.00 |
| Earnings from Continuing Operations | 0.01 | -4.06 | -8.49 | -8.97 | -16.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.40K | -4.06M | -8.49M | -8.97M | -16.35M |
| EBIT | -1.16M | -5.29M | -9.71M | -10.37M | -17.93M |
| EBITDA | -1.11M | -5.26M | -9.67M | -10.34M | -17.90M |
| EPS Basic | 0.01 | -0.76 | -1.60 | -1.70 | -3.10 |
| Normalized Basic EPS | 0.00 | -0.47 | -1.00 | -1.06 | -1.94 |
| EPS Diluted | -0.04 | -0.79 | -1.62 | -1.72 | -3.14 |
| Normalized Diluted EPS | -0.01 | -0.48 | -1.00 | -1.07 | -1.94 |
| Average Basic Shares Outstanding | 21.36M | 21.32M | 21.27M | 21.16M | 21.08M |
| Average Diluted Shares Outstanding | 21.73M | 21.37M | 21.31M | 21.20M | 21.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |